Presentation TCT 2016 Potential Advantages and Pitfalls of Bioabsorbable Polymers Presenter: Stephan Windecker, Renu Virmani October 31, 2016
Presentation TCT 2016 EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease Presenter: Martin B. Leon, Keith G. Oldroyd, Gregg W. Stone October 31, 2016
Presentation TCT 2016 The Newest Durable Polymer-Based DES: BioNir and Outcomes From Nireus Phase II and Bionics Pivotal Trials Presenter: Donald Cutlip, Christian Hengstenberg, David E. Kandzari October 31, 2016
Presentation TCT 2016 Can Passive Coatings Make a Difference: Results With the COBRA PzF Nanocoated Coronary Stent Presenter: Donald Cutlip, Christian Hengstenberg, Sigmund Silber October 31, 2016
Presentation TCT 2016 Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy Presenter: Donald Cutlip, Christian Hengstenberg, David G. Rizik October 31, 2016
Presentation TCT 2016 Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy Presenter: Donald Cutlip, Christian Hengstenberg, Michael Joner October 31, 2016
Presentation TCT 2016 Rationale for and Design of ABSORB IV (Five-Year Results): What I Expect the Findings to Be But What Wont Surprise Me! Presenter: Jorge Gaspar, Davide Capodanno October 30, 2016
Presentation TCT 2016 Case Presentation: Evaluation and Management of Recurrent DES Restenosis Presenter: Fernando Alfonso, Stephan Windecker, Adnan K. Chhatriwalla October 30, 2016
Presentation TCT 2016 Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis? Presenter: Fernando Alfonso, Stephan Windecker, Ron Waksman October 30, 2016
Presentation TCT 2016 Prognosis and Treatment Options for DES Restenosis and Re-restenosis Presenter: Fernando Alfonso, Stephan Windecker October 30, 2016
Presentation TCT 2016 Case Presentation: A Surprise in the Evaluation and Management of Stent Thrombosis Presenter: Fernando Alfonso, Stephan Windecker, Ehrin J. Armstrong October 30, 2016
News Conference News TCT 2016 BIONICS: Ridaforolimus-Eluting Stent Noninferior to Zotarolimus Stent at 1 Year TCT Daily Staff October 30, 2016
Presentation TCT 2016 How to Evaluate and Treat the Patient With Metallic Stent Thrombosis: The Usual Suspects and Beyond Presenter: Fernando Alfonso, Stephan Windecker, Giulio G. Stefanini October 30, 2016
Presentation TCT 2016 Are All Stent Thromboses Prognostically Created Equal? Impact of Original Clinical Presentation, Stent Location and Thrombosis Timing Presenter: Fernando Alfonso, Stephan Windecker, Robert-Jan van Geuns October 30, 2016
Presentation TCT 2016 Is the OCT-derived Healing Score A Meaningful Metric to Evaluate Stent Safety? Presenter: Fernando Alfonso, Stephan Windecker, Giulio Guagliumi October 30, 2016
Presentation TCT 2016 OCT-assessed Rate of Early Strut Coverage: Differences Between DES and Its Implications Presenter: Fernando Alfonso, Stephan Windecker, Stephen WL Lee October 30, 2016
Presentation TCT 2016 Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified Diffuse Stenosis: How Did I Treat? Presenter: Jun-Jack Cheng, Yoshito Yamamoto, Linda Lison October 30, 2016
Presentation TCT 2016 Is Acute or Late Acquired Malapposition By IVUS or OCT A Risk Factor for Stent Thrombosis? Presenter: Fernando Alfonso, Stephan Windecker, Gary S. Mintz October 30, 2016
Presentation TCT 2016 Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified Diffuse Stenosis: Case Introduction Presenter: Jun-Jack Cheng, Yoshito Yamamoto, Linda Lison October 30, 2016
Presentation TCT 2016 New Insights Into the Mechanisms and Patterns of in-stent Restenosis in BMS and DES Evaluated By IVUS and OCT (With Case Examples) Presenter: Fernando Alfonso, Stephan Windecker, Akiko Maehara October 30, 2016